These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 27003684)
1. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice. Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p. Yan C; Li J; Feng S; Li Y; Tan L Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1. Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis. Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223 [TBL] [Abstract][Full Text] [Related]
5. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression. Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W Int J Mol Med; 2019 Jan; 43(1):345-357. PubMed ID: 30431065 [TBL] [Abstract][Full Text] [Related]
6. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1. Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292 [TBL] [Abstract][Full Text] [Related]
7. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice. Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin F Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555 [TBL] [Abstract][Full Text] [Related]
9. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells. Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220 [No Abstract] [Full Text] [Related]
10. MicroRNA-721 regulates gluconeogenesis via KDM2A-mediated epigenetic modulation in diet-induced insulin resistance in C57BL/6J mice. Kabeer SW; Sharma S; Sriramdasu S; Tikoo K Biol Res; 2024 May; 57(1):27. PubMed ID: 38745315 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase. Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967 [No Abstract] [Full Text] [Related]
12. Leptin suppresses microRNA-122 promoter activity by phosphorylation of foxO1 in hepatic stellate cell contributing to leptin promotion of mouse liver fibrosis. Cao Q; Zhu X; Zhai X; Ji L; Cheng F; Zhu Y; Yu P; Zhou Y Toxicol Appl Pharmacol; 2018 Jan; 339():143-150. PubMed ID: 29248466 [TBL] [Abstract][Full Text] [Related]
13. Palmitic acid reduces the methylation of the FOXO1 promoter to suppress the development of diffuse large B-cell lymphoma via modulating the miR-429/DNMT3A axis. Li W; Gao M; Xue W; Li X; Chang Y; Zhang K; Wen C; Zhang M Chin J Nat Med; 2024 Jun; 22(6):554-567. PubMed ID: 38906602 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance. Song Y; Wu L; Li M; Xiong X; Fang Z; Zhou J; Yan G; Chen X; Yang J; Li Y EBioMedicine; 2019 Apr; 42():494-503. PubMed ID: 30948354 [TBL] [Abstract][Full Text] [Related]
15. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver. Tian F; Ying HM; Wang YY; Cheng BN; Chen J Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762 [TBL] [Abstract][Full Text] [Related]
17. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1. Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265 [TBL] [Abstract][Full Text] [Related]
18. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK). Sun WX; Lou K; Chen LJ; Liu SD; Pang SG J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221 [TBL] [Abstract][Full Text] [Related]
19. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis. Kurano M; Hara M; Satoh H; Tsukamoto K Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144 [TBL] [Abstract][Full Text] [Related]
20. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice. Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]